Srini Pharmaceuticals

CAS 521284-19-5

Chemistry, 5 End Use API, 44 Related Intermediates

Manufacturers/Suppliers

5 Suppliers

5 Suppliers

Also known as: 521284-19-5, (2r)-2-hydroxy-n-[2-(4-nitrophenyl)ethyl]-2-phenylacetamide, (r)-n-(4-nitrophenethyl)-2-hydroxy-2-phenylacetamide, (alphar)-alpha-hydroxy-n-[2-(4-nitrophenyl)ethyl]benzeneacetamide, Schembl1405355, Mfcd22200231

Molecular Formula

C₁₆H₁₆N₂O₄

Molecular Weight

300.31 g/mol

InChI Key

YWGDTDSOHPHFAQ-OAHLLOKOSA-N

1 2D Structure

CAS 521284-19-5

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(2R)-2-hydroxy-N-[2-(4-nitrophenyl)ethyl]-2-phenylacetamide

2.1.2 InChI

InChI=1S/C16H16N2O4/c19-15(13-4-2-1-3-5-13)16(20)17-11-10-12-6-8-14(9-7-12)18(21)22/h1-9,15,19H,10-11H2,(H,17,20)/t15-/m1/s1

2.1.3 InChI Key

YWGDTDSOHPHFAQ-OAHLLOKOSA-N

2.1.4 Canonical SMILES

C1=CC=C(C=C1)C(C(=O)NCCC2=CC=C(C=C2)[N+](=O)[O-])O

2.1.5 Isomeric SMILES

C1=CC=C(C=C1)[C@H](C(=O)NCCC2=CC=C(C=C2)[N+](=O)[O-])O

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 521284-19-5

2. (2r)-2-hydroxy-n-[2-(4-nitrophenyl)ethyl]-2-phenylacetamide

3. (r)-n-(4-nitrophenethyl)-2-hydroxy-2-phenylacetamide

4. (alphar)-alpha-hydroxy-n-[2-(4-nitrophenyl)ethyl]benzeneacetamide

5. Schembl1405355

6. Mfcd22200231

7. Zinc73032732

8. Akos024464728

9. Ds-7812

10. Ac-26408

11. Cs-0149883

12. (r)-n-(4-nitrophenethyl)-2-phenyl-2-hydroxyacetamide

13. (r)-2-hydroxy-n-[2-(4-nitro-phenyl)ethyl]-2-phenylacetamide

14. (r)-2-hydroxy-n-[2-(4-nitrophenyl)ethyl]-2-phenylacetamide

2.3 Create Date

2012-08-20

3 Chemical and Physical Properties

Molecular Formula	C₁₆H₁₆N₂O₄
Molecular Weight	300.31 g/mol
XLogP3	2.4
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	5
Exact Mass	300.11100700 g/mol
Monoisotopic Mass	300.11100700 g/mol
Topological Polar Surface Area	95.2 Å²
Heavy Atom Count	22
Formal Charge	0
Complexity	369
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

India

Virtual Booth

Digital Content

Mirabegron

PDF Supplier PDF

URL Supplier Web Content

CAS Number

66659-20-9

End Use API

Mirabegron

About the Company

Srini Pharmaceuticals Pvt. Ltd., was established in 1995. USFDA, TGA and KFDA approved fully integrated g...

Srini Pharmaceuticals Pvt. Ltd., was established in 1995. USFDA, TGA and KFDA approved fully integrated global pharmaceutical company, located just about 60 KM's away from the Pharma Capital of India, Hyderabad. Our manufacturing facility has five fully equipped production blocks with most efficient functional utilities with multiple clean rooms having the ability to produce 10 API's at a time, supported by central quality control laborites with all sophisticated instruments by maintaining complete QMS.

ASK
US